|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107 ILa | -5.98% |
|
-1.11% | -15.88% |
| 2023 | Nextgen Biomed Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Nextgen Biomed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Nextgen Biomed Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was ILS 2.09 million compared to ILS 1.66 million a year ago. Basic loss per share from continuing operations was ILS 0.289 compared to ILS 0.228 a year ago.
Diluted loss per share from continuing operations was ILS 0.289.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.88% | 2.03M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +4.01% | 1.13B |
NEXTGEN BIOMED LTD 
